The Level of hs-CRP in Coronary Artery Ectasia and Its Response to Statin and Angiotensin-Converting Enzyme Inhibitor Treatment

Ozbay, Yilmaz; Akbulut, Mehmet; Balin, Mehmet; Kayancicek, Hidayet; Baydas, Adil; Korkmaz, Hasan

doi:https://doi.org/10.1155/2007/89649

Mediators of Inflammation

On this page

Abstract References Copyright Related Articles

Research Article | Open Access

Volume 2007 | Article ID 089649 | https://doi.org/10.1155/2007/89649

The Level of hs-CRP in Coronary Artery Ectasia and Its Response to Statin and Angiotensin-Converting Enzyme Inhibitor Treatment

Yilmaz Ozbay,¹Mehmet Akbulut,¹Mehmet Balin,¹Hidayet Kayancicek,¹Adil Baydas,¹and Hasan Korkmaz¹

Received13 Oct 2006

Revised13 Nov 2006

Accepted16 Nov 2006

Published27 Dec 2006

Abstract

Background/Aim. Coronary artery ectasia (CAE) was thought of as a variant of atherosclerosis. C-reactive protein (CRP) which is among the most sensitive markers of systemic inflammation, and elevation of systemic and local levels of this inflammatory marker which has been associated with an increased risk for cardiovascular disease in the obstructive coronary artery disease (O-CAD) are well known, but little was known in CAE. The anti-inflammatory effects of statins and the effect of angiotensin-converting enzyme (ACE) inhibitors on endothelial dysfunction are well established in atherosclerosis. The aim of the present study was to investigate CRP level and its response to statin and ACE inhibitor treatment in CAE. Materials and method. We measured serum hs-CRP level in 40 CAE (26 males, mean age: 56.32±9 years) and 41 O-CAD (34 males, mean age: 57.19±10 years) patients referred for elective coronary angiography at baseline and after 3-month statin and ACE inhibitor treatment. Results. Plasma hs-CRP levels were significantly higher in CAE group than O-CAD group at baseline (2.68±66 mg/L versus 1,64±64, resp., P<.0001). Plasma hs-CRP levels significantly decreased from baseline 3 months later in the CE (from 2.68±0.66 mg/L to 1.2±0.53 mg/L, P<.0001) as well as in the O-CAD group (from 1.64±0.64 mg/L to 1.01±0.56 mg/L, P<.001). Conclusion. We think that hs-CRP measurement may be a good prognostic value in CAE patients as in stenotic ones. Further placebo-controlled studies are needed to evaluate the clinical significance of this decrease in hs-CRP.

References

P. S. Swaye, L. D. Fisher, P. Litwin et al., “Aneurysmal coronary artery disease,” Circulation, vol. 67, no. 1, pp. 134–138, 1983.
View at: Google Scholar
R. Seabra Gomes, J. Somerville, D. N. Ross, R. Emanuel, D. J. Parker, and M. Wong, “Congenital coronary artery aneurysms,” British Heart Journal, vol. 36, no. 4, pp. 329–335, 1974.
View at: Google Scholar
V. O. Björk and L. Björk, “Intramural coronary artery aneurysm. A coronary artery steal syndrome,” Journal of Thoracic and Cardiovascular Surgery, vol. 54, no. 1, pp. 50–52, 1967.
View at: Google Scholar
W. V. R. Vieweg, J. S. Alpert, and A. D. Hagan, “Caliber and distribution of normal coronary arterial anatomy,” Catheterization and Cardiovascular Diagnosis, vol. 2, no. 3, pp. 269–280, 1976.
View at: Google Scholar
V. L. Sorrell, M. J. Davis, and A. A. Bove, “Current knowledge and significance of coronary artery ectasia: a chronologic review of the literature, recommendations for treatment, possible etiologies, and future considerations,” Clinical Cardiology, vol. 21, no. 3, pp. 157–160, 1998.
View at: Google Scholar
J. E. Markis, C. D. Joffe, P. F. Cohn, D. J. Feen, M. V. Herman, and R. Gorlin, “Clinical significance of coronary arterial ectasia,” American Journal of Cardiology, vol. 37, no. 2, pp. 217–222, 1976.
View at: Publisher Site | Google Scholar
C. Gabay and I. Kushner, “Acute-phase proteins and other systemic responses to inflammation,” New England Journal of Medicine, vol. 340, no. 6, pp. 448–454, 1999.
View at: Publisher Site | Google Scholar
L. M. Biasucci, C. Colizzi, V. Rizzello, G. Vitrella, F. Crea, and G. Liuzzo, “Role in inflammation in the pathogenesis of unstable coronary artery diseases,” Scandinavian Journal of Clinical and Laboratory Investigation. Supplement, vol. 59, no. 230, pp. 12–22, 1999.
View at: Google Scholar
H. Turhan, A. R. Erbay, A. S. Yasar, M. Balci, A. Bicer, and E. Yetkin, “Comparison of C-reactive protein levels in patients with coronary artery ectasia versus patients with obstructive coronary artery disease,” American Journal of Cardiology, vol. 94, no. 10, pp. 1303–1306, 2004.
View at: Publisher Site | Google Scholar
A. Finkelstein, Y. Michowitz, A. Abashidze, H. Miller, G. Keren, and J. George, “Temporal association between circulating proteolytic, inflammatory and neurohormonal markers in patients with coronary ectasia,” Atherosclerosis, vol. 179, no. 2, pp. 353–359, 2005.
View at: Publisher Site | Google Scholar
K. Kajinami, S. Kasashima, Y. Oda, J. Koizumi, S. Katsuda, and H. Mabuchi, “Coronary ectasia in familial hypercholesterolemia: histopathologic study regarding matrix metalloproteinases,” Modern Pathology, vol. 12, no. 12, pp. 1174–1180, 1999.
View at: Google Scholar
P. Libby, P. M. Ridker, and A. Maseri, “Inflammation and atherosclerosis,” Circulation, vol. 105, no. 9, pp. 1135–1143, 2002.
View at: Publisher Site | Google Scholar
P. M. Ridker, “Clinical application of C-reactive protein for cardiovascular disease detection and prevention,” Circulation, vol. 107, no. 3, pp. 363–369, 2003.
View at: Publisher Site | Google Scholar
P. M. Ridker, N. Rifai, L. Rose, J. E. Buring, and N. R. Cook, “Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events,” New England Journal of Medicine, vol. 347, no. 20, pp. 1557–1565, 2002.
View at: Publisher Site | Google Scholar
C. M. Albert, J. Ma, N. Rifai, M. J. Stampfer, and P. M. Ridker, “Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death,” Circulation, vol. 105, no. 22, pp. 2595–2599, 2002.
View at: Publisher Site | Google Scholar
P. M. Ridker, M. J. Stampfer, and N. Rifai, “Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease,” Journal of the American Medical Association, vol. 285, no. 19, pp. 2481–2485, 2001.
View at: Publisher Site | Google Scholar
R. Kranzhöfer, J. Schmidt, C. A. H. Pfeiffer, S. Hagl, P. Libby, and W. Kübler, “Angiotensin induces inflammatory activation of human vascular smooth muscle cells,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 19, no. 7, pp. 1623–1629, 1999.
View at: Google Scholar
P. E. Tummala, X.-L. Chen, C. L. Sundell et al., “Angiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculature: a potential link between the renin-angiotensin system and atherosclerosis,” Circulation, vol. 100, no. 11, pp. 1223–1229, 1999.
View at: Google Scholar
J. P. Tsikouris, J. Simoni, J. A. Suarez, P. Sutthiwan, M. Ziska, and G. E. Meyerrose, “Comparison of effects of quinapril versus enalapril on vasoactive substances following acute myocardial infarction,” American Journal of Cardiology, vol. 94, no. 5, pp. 641–643, 2004.
View at: Publisher Site | Google Scholar
K. M. Fox, “Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). EURopan trial on reduction of cardiac events with perindopril in stable coronary artery disease investigators,” Lancet, vol. 362, no. 9386, pp. 782–788, 2003.
View at: Publisher Site | Google Scholar
M. J. A. Williams and R. A. H. Stewart, “Coronary artery ectasia: local pathology or diffuse disease?” Catheterization and Cardiovascular Diagnosis, vol. 33, no. 2, pp. 116–119, 1994.
View at: Google Scholar
J. T. Powell, B. R. Muller, and R. M. Greenhalgh, “Acute phase proteins in patients with abdominal aortic aneurysms,” Journal of Cardiovascular Surgery, vol. 28, no. 5, pp. 528–530, 1987.
View at: Google Scholar
P. Farto e Abreu, A. Mesquita, J. A. Silva, and R. Seabra-Gomes, “Coronary artery ectasia: clinical and angiographic characteristics and prognosis,” Revista Portuguesa de Cardiologia, vol. 12, no. 4, pp. 305–310, 1993.
View at: Google Scholar
Y. Gunes, B. Boztosun, A. Yildiz et al., “Clinical profile and outcome of coronary artery ectasia,” Heart, vol. 92, no. 8, pp. 1159–1160, 2006.
View at: Publisher Site | Google Scholar
G. D. Giannoglou, A. P. Antoniadis, Y. S. Chatzizisis, E. Damvopoulou, G. E. Parcharidis, and G. E. Louridas, “Prevalence of ectasia in human coronary arteries in patients in northern Greece referred for coronary angiography,” American Journal of Cardiology, vol. 98, no. 3, pp. 314–318, 2006.
View at: Publisher Site | Google Scholar
A. E. Androulakis, G. K. Andrikopoulos, A. N. Kartalis et al., “Relation of coronary artery ectasia to diabetes mellitus,” American Journal of Cardiology, vol. 93, no. 9, pp. 1165–1167, 2004.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2007 Yilmaz Ozbay et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation Order printed copies

Views

348

Downloads

806

Citations